Oncotarget

Vol 3, No 7

July 2012

View Archive »

Order a Reprint

About The Cover

ALT associates with the ATRX alterations and the I-A signature. A representative image of a grade III astrocytoma section that was positive for both ALT and for p53 nuclear staining is shown in Figure 3 of Jiao et al. The dynamic range of the image was digitally altered for the July cover of Oncotarget. See Jiao et al.

Table of Contents

Editorial

Mutations in circulating mitochondrial DNA: Cassandra of oral cancer?

Mutations in circulating mitochondrial DNA: Cassandra of oral cancer?

https://doi.org/10.18632/oncotarget.567

Eugene S. Kandel
664-665
PDF  |  HTML  |  Order a Reprint

Engineering Enzymatically Activated “Molecular Grenades” for Cancer

Engineering Enzymatically Activated “Molecular Grenades” for Cancer

https://doi.org/10.18632/oncotarget.562

Samuel R. Denmeade,  and John T. Isaacs
666-667
PDF  |  HTML  |  Order a Reprint

Folate Receptor Alpha: A New Tool in the Diagnosis and Treatment of Lung Cancer

Folate Receptor Alpha: A New Tool in the Diagnosis and Treatment of Lung Cancer

https://doi.org/10.18632/oncotarget.575

Laura D. Wood
668-669
PDF  |  HTML  |  Order a Reprint

Brief Reports

Circulating tumor-derived mutant mitochondrial DNA: a predictive biomarker of clinical prognosis in human squamous cell carcinoma.

Circulating tumor-derived mutant mitochondrial DNA: a predictive biomarker of clinical prognosis in human squamous cell carcinoma.

https://doi.org/10.18632/oncotarget.523

Katsuhiro Uzawa, Takao Baba, Fumihiko Uchida, Masanobu Yamatoji, Atsushi Kasamatsu, Yosuke Sakamoto, Katsunori Ogawara, Masashi Shiiba, Hiroki Bukawa,  and Hideki Tanzawa
670-677
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Research Papers

A thymidylate synthase ternary complex-specific antibody, FTS, permits functional monitoring of fluoropyrimidines dosing

A thymidylate synthase ternary complex-specific antibody, FTS, permits functional monitoring of fluoropyrimidines dosing

https://doi.org/10.18632/oncotarget.554

Kalpesh Patel, Sashidhar R. Yerram, Nilofer A. Azad,  and Scott E. Kern
678-685
Abstract  |  PDF  |  HTML  |  Order a Reprint

Receptor-targeted therapy of human experimental urinary bladder cancers with cytotoxic LH-RH analog AN-152 (AEZS-108)

Receptor-targeted therapy of human experimental urinary bladder cancers with cytotoxic LH-RH analog AN-152 (AEZS-108)

https://doi.org/10.18632/oncotarget.546

Karoly Szepeshazi, Andrew V Schally, Gunhild Keller, Norman L Block, Daniel Benten, Gabor Halmos, Luca Szalontay, Irving Vidaurre, Miklos Jaszberenyi,  and Ferenc G Rick
686-699
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

The response to PAK1 inhibitor IPA3 distinguishes between cancer cells with mutations in BRAF and Ras oncogenes

The response to PAK1 inhibitor IPA3 distinguishes between cancer cells with mutations in BRAF and Ras oncogenes

https://doi.org/10.18632/oncotarget.587

Ruchi Singhal,  and Eugene S. Kandel
700-708
Abstract  |  PDF  |  HTML  |  Order a Reprint

Frequent ATRX, CIC, FUBP1 and IDH1 mutations refine the classification of malignant gliomas

Frequent ATRX, CIC, FUBP1 and IDH1 mutations refine the classification of malignant gliomas

https://doi.org/10.18632/oncotarget.588

Yuchen Jiao, Patrick J. Killela, Zachary J. Reitman, B.Ahmed Rasheed, Christopher M. Heaphy, Roeland F. de Wilde, Fausto J. Rodriguez, Sergio Rosemberg, Sueli Meiko Obashinjo, Suely Kazue Nagahashi Marie, Chetan Bettegowda, Nishant Agrawal, Eric Lipp, Christopher Pirozzi, Giselle Lopez, Yiping He, Henry Friedman, Allan H. Friedman, Gregory J. Riggins, Matthias Holdhoff, Peter Burger, Roger McLendon, Darell D. Bigner, Bert Vogelstein, Alan K. Meeker, Kenneth W. Kinzler, Nickolas Papadopoulos, Luis A. Diaz, Jr.,  and Hai Yan
709-722
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

NEDD9, a novel target of miR-145, increases the invasiveness of glioblastoma

NEDD9, a novel target of miR-145, increases the invasiveness of glioblastoma

https://doi.org/10.18632/oncotarget.547

Maria Carmela Speranza, Véronique Frattini, Federica Pisati, Dimos Kapetis, Paola Porrati, Marica Eoli, Serena Pellegatta,  and Gaetano Finocchiaro
723-734
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint


Copyright © 2017 Impact Journals
Impact Journals is a registered trademark of Impact Journals, LLC